-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Vistagen Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q3 2024.
- Vistagen Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.11M, a 90.4% increase year-over-year.
- Vistagen Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $3.3M, a 32% increase year-over-year.
- Vistagen Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.18M, a 34.6% decline from 2022.
- Vistagen Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.34M, a 4.13% decline from 2021.
- Vistagen Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.48M, a 50.9% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)